Highlights d m 6 A/m mRNA methylation in the adult mouse brain is regulated by stress d m 6 A/m mRNA regulation is brain region, time, and gene specific d Mettl3 and Fto cKO alter m 6 A/m, fear memory, expression, and synaptic plasticity d The m 6 A/m glucocorticoid response is impaired in major depressive disorder patients Correspondence alon_chen@psych.mpg.de In Brief Engel et al. demonstrate a region-and time-dependent role of brain m 6 A/m methylation in stress-response regulation. Manipulating m 6 A/m alters fear memory, transcriptome response, and synaptic plasticity. Altered m 6 A/m dynamics in depressed patients suggest importance of m 6 A/m modifications for stress-related psychiatric disorders.
INTRODUCTION
Regulation of gene expression in response to stressful stimuli under healthy or pathological conditions involves epigenetic mechanisms such as DNA methylation and chromatin modifications (de Kloet et al., 2005; McEwen et al., 2015) . Elucidating the underlying molecular processes that regulate the fine-tuned transcriptional response to stress is essential for understanding stress vulnerability and the development of stress-related psychiatric disorders such as depression and anxiety.
In analogy to DNA modifications, a diverse set of covalent modifications is present on RNA nucleotides encoding the epitranscriptome, post-transcriptionally shaping gene expression via regulation of RNA stability, translation, and non-coding transcript function (Zhao et al., 2017) . The role of this newly emerging layer of gene expression control in the central stress response and behavior is not fully understood yet (Engel and Chen, 2018) . RNA modifications, next to epigenetic mechanisms, likely represent a yet undescribed level of transcriptional regulation highly relevant for psychiatry. N 6 -methyladenosine (m 6 A) is the most abundant internal mRNA modification, which is present transcriptome-wide in at least one-fourth of all RNAs, typically located in a consensus motif (DRACH/GGACU), and enriched near stop codons and in 5 0 UTRs Linder et al., 2015; Meyer et al., 2012) . Recent studies have identified mammalian m 6 A to be dynamically regulated, controlling stem cell proliferation and differentiation (Klungland et al., 2016) , cellular heat-shock response (Zhou et al., 2015) , DNA damage response (Xiang et al., 2017) , and tumorigenesis (Cui et al., 2017) . Brain RNA methylation is comparably high and increases during development . m 6 A is deposited co-transcriptionally (Ke et al., 2017; Slobodin et al., 2017) by a methyltransferase complex consisting of METTL3, METTL14 , WTAP (Ping et al., 2014) , KIAA1429 (VIR; Schwartz et al., 2014) , and RBM15/RBM15B (Patil et al., 2016) . In contrast, it can be removed by the demethylases FTO Mauer et al., 2017) and ALKBH5 . FTO further catalyzes the demethylation of N 6 ,2 0 -O-dimethyladenosine (m 6 Am) with an in vitro preference for this substrate . m 6 Am is found at the first nucleotide adjacent to the 7-methylguanosine cap, promoting transcript stability . Fto has been associated with memory consolidation (Walters et al., 2017; Widagdo et al., 2016) and was implicated in regulation of dopaminergic brain networks . The most commonly used m 6 A/m antibody, used also in most experiments presented here, co-detects m 6 A and m 6 Am , potentially preventing clear discrimination between them. Therefore, data will be treated as potentially containing both and called m 6 A/m unless otherwise stated.
In general, m 6 A/m-regulating enzymes may be expressed at different levels in different cell types and have distinct intracellular distributions and binding motifs and thus potentially affect different subsets of target RNAs. Cellular consequences of m 6 A/m modifications depend on the binding of m 6 A/m-reader proteins (such as YTH and HNRNP proteins) and include RNA maturation, splicing, alternative polyadenylation, RNA decay, and both promotion and inhibition of protein translation (reviewed in Peer et al., 2017 .
In this study, we aimed to elucidate the role of m 6 A/m in the context of the brain's stress response. We delineated the effects of acute stress on m 6 A/m using global m 6 A/m measurements, m 6 A/m sequencing (m 6 A/m-seq), and absolute quantification of transcript-specific methylation levels. In addition, we explored the functional significance of m 6 A/m in the adult brain by examining conditional knockout (cKO) mice for Mettl3 and Fto. Finally, we investigated m 6 A/m regulation in blood samples of mice and humans to determine its potential as a peripheral indicator of the central response to stress and stress-linked psychiatric disorders.
RESULTS
The Stress-Induced m 6 A/m Epitranscriptome To test whether acute stress alters m 6 A/m, we performed m 6 A/m-seq (RNA-seq after immunoprecipitation) on mouse cortex poly(A)-RNA 4 hr following 15 min of acute restraint stress exposure (n = 6-7). Using more specific areas, and thus lower amounts of input material, was not sufficient for consistent, quantifiable poly(A)-m 6 A/m-seq. The peaks enriched in the m 6 A/m-RIP (RNA immunoprecipitation)-seq over the input-RNA-seq in the two different conditions were very similar (Figures S1A and S1B). We analyzed differential methylation across an m 6 A/m consensus peak set with 14,656 high-confidence m 6 A/m peaks (supported by either 2/3 samples per group or 1/ 2 of all samples and additional abundance filters) mapping to 7,982 genes ( Figure 1A ; Table S1 ). Thus, around half of the expressed genes in the mouse cortex are m 6 A/m methylated with each around 2 peaks per gene ( Figure 1A ). m 6 A/m peaks overlapped majorly with previously reported m 6 A/m peaks (85% overlap with RMBase 2; Xuan et al., 2018) , preferentially located to the 5 0 UTR and around the stop codon ( Figure 1B) , and contained the m 6 A consensus motif with the top motif being a centrally enriched GGACWB ( Figure 1C ). m 6 A/m methylation in the cortex is overrepresented in genes involved in synaptic and neuronal regulation ( Figure S1C ).
Only 25 m 6 A/m peaks (in 20 different genes) and 13 genes were found to be significantly regulated 4 hr after stress, but all with very low fold changes (at absolute log2 fold change > 0.2 for m 6 A, > 0.1 for RNA, and Q < 0.1; Figures 1A and S1D-S1G; two examples including validation by m 6 A-RIP-qPCR are shown in Figure 1D ), potentially reflecting the cellular heterogeneity of the input material used diluting the cell-specific effects of stress. RNAs and m 6 A/m peaks significantly regulated by stress showed only low overlap (three genes) and no prominent correlation of m 6 A/m and gene expression regulation by stress ( Figure S1E ).
To investigate if m 6 A and m 6 Am may have different effects after stress, we in silico dissected m 6 A and m 6 Am peaks based on the assumption that m 6 Am occurred at the first nucleotide after the transcription start site (similar to strategies employed earlier by Linder et al., 2015 and Mauer et al., 2017) . We observed 1,801 putative m 6 Am peaks (12%; Figures 1E and S2A ) with highest gene ontology enrichment in developmental genes and genes related to DNA and RNA rather than neuronal genes ( Figure S2B ) and no enrichment of a GGAC motif (data not shown). Putative m 6 Am peaks were not overrepresented in stress-regulated peaks (data not shown), and had similar stress regulation like all peaks ( Figure S2C ) and similar absence of correlation to stress regulation of gene expression ( Figure S2C ), overall not indicating a special role of m 6 Am in the stress response. Further, in order to assess potential regulation of transcript translation by stress-regulated m 6 A/m, we performed ribosome profiling on mouse cortex 4 hr after stress. Although there were several genes with regulated translation efficiency after stress (24 genes at Q < 0.1, absolute log2 fold changes > 0.5), none overlapped with stress-regulated m 6 A/m and there was also no apparent relation to stress regulation of m 6 A/m ( Figure 1F ). Finally, searching for potential binding factors for m 6 A/m, we analyzed the cooccurrence of the overserved m 6 A motif GGACWB to known binding motifs of RNA-binding proteins in the m 6 A/m-seq fragments, observing a high similarity and summit enrichment to the binding motifs of FMRP/FMR1 and FXR2, proteins crucial for translation regulation, RNA translocation, and synaptic plasticity in neurons ( Figure S2D ). Likewise, genes reported to be bound by mouse FMRP were also higher than likely m 6 A/m methylated ( Figure S2E ), suggesting that m 6 A/m methylation of neuronal RNAs may regulate protein binding critical for neuronal transport and plasticity.
Stress Regulation of m 6 A/m Is Brain Region Specific
Based on both the number of significantly stress-regulated m 6 A/m peaks and their respective fold changes in m 6 A/m-seq being very small, we reasoned that the true extent of the m 6 A/m stress response may only be revealed when investigating more defined brain regions. Therefore, we measured the time course of RNA methylation changes in two regions highly involved in stress response regulation: the medial prefrontal cortex (PFC) and the basolateral and central amygdala (AMY; Figure 2A) . We found that global m 6 A/m was regulated in total RNA in a region-dependent manner with RNA methylation decreased in the PFC and increased in the AMY ( Figure 2B ). The same regulation was observed when only m 6 A was measured in mRNA using liquid chromatography-tandem mass spectrometry (LC-MS/MS) ( Figure 2C ), arguing for m 6 A as the main driver of the observed effects. Examining changes of the m 6 A/m machinery related to these global changes, we measured gene expression levels of m 6 A/m enzymes and binding proteins. We found the demethylases Fto and Alkbh5 to be differentially regulated in a region-specific manner, facilitating the effects (A) Approximately half of the genes expressed in the mouse cortex are m 6 A/m methylated, but only a minor fraction is regulated by acute stress on cortex-wide level. m 6 A/m-seq of mouse cortex poly(A)-RNA basal or 4 hr after 15 min restraint stress; n = 6-7, each pooled from 3 mice. Stress-regulated m 6 A/m peaks, Q < 0.1 and absolute log2 fold change > 0.2; stress-regulated mRNAs ( = differential expressed genes), Q < 0.1 and absolute log2 fold change > 0.1. (B) m 6 A/m peaks are enriched at the 5 0 UTR and the stop codon with similar distribution of all and stress-regulated peaks (peak distribution mapped along mRNA relative position). (C) GGACWB is the most abundant motif detected in m 6 A/m peaks and enriched at peak summits. Top enriched sequence motif and its position across the detected m 6 A/m peaks. GGAC was detected in 84%, GGACWB in 63% of the peaks. (D) Two examples of stress-regulated m 6 A/m peaks and replication of their quantitative regulation by m 6 A/m-RNA immunoprecipitation (RIP)-qPCR in an unrelated cohort of animals. Left panel per gene: averaged sequence tracks and peaks; arrows indicate quantitatively regulated peaks. Right panel per gene: differential methylation was validated in a separate cohort of mice using full-length m 6 A/m-RIP-qPCR, including an intermediated time point (1 hr). n = 7, mean ± SEM; asterisks [*] depict omnibus Tukey post hoc tests to basal p < 0.05 after FDR-corrected one-way ANOVA. (E) Bioinformatic dissection of m 6 Am peaks based on their position at the transcription start site, observing 1,801 putative m 6 Am sites. m 6 Am peaks do not show a preference for stress-regulated peaks. (F) Regulation of translation efficiency (TE assessed by ribosome profiling) by stress does not correlate well or overlap with regulation of m 6 A/m methylation. n = 6 for ribosome profiling; n = 6-7 for m 6 A/m profiling. Shown are fold changes upon stress using only genes abundantly detected in ribosome profiling sequencing with significance determined by Q < 0.1 and absolute log2 fold change > 0.2. See also Figures S1 and S2 and Table S1. observed on global methylation, in most cases preceding the effect observed on global m 6 A/m ( Figure 2D ). Furthermore, Mettl3 was downregulated upon stress exposure tissue independently ( Figure 2D ) and Wtap was regulated isoform specifically only in the AMY ( Figure S3A ). The m 6 A/m reader Ythdc1 was regulated in a region-specific manner ( Figure 2D ), whereas the other known enzymes and readers were not differentially expressed ( Figure S3A ).
Notably, intraperitoneal (i.p.) injection of the endogenous glucocorticoid corticosterone, but not the glucocorticoid receptor agonist dexamethasone, changed global m 6 A/m ( Figure 2E ), as well as Fto and Alkbh5 expression ( Figure S3B ), similarly to acute stress ( Figure 2D ), demonstrating that the stress effect may be mediated by endogenous glucocorticoids (GCs). Supporting this idea, we found that the majority of m 6 A/m enzyme and reader genes contain several GC response elements in their 5 0 upstream region, likewise pointing at expression regulation of those genes via GCs ( Figure S3C ).
Stress Regulation of m 6 A/m Is Gene Specific m 6 A/m-seq not only requires large amounts of input material but also does not quantify absolute transcript methylation. Therefore, we performed m 6 A/m-RIP followed by qPCR to assess absolute levels of candidate transcript methylation in narrowly defined brain areas, before and after stressful challenge. For calibration of the assay and normalization of immunoprecipitation efficiency in experiments, we designed and used an m 6 A/m-methylated internal spike-in RNA oligonucleotide ( Figures 3A, S4A , and S4B). The m 6 A/m-RIP-qPCR detected m 6 A/m methylated RNA spike-in across a wide range of concentrations with low IgG background signal and without competing with the immunoprecipitation of endogenously methylated RNAs ( Figure 3B ). Using mixtures of unmethylated and methylated spike-in oligonucleotides, we confirmed that m 6 A/m-RIP-qPCR measured different methylation states of RNAs with high precision ( Figure 3C ; r 2 > 0.95).
Applying m 6 A/m-RIP-qPCR, we measured absolute methylation levels of several candidate transcripts involved in the Figure S3 . n = 12, log2 fold change ± SEM; two-way MANOVA, significant interaction effects for Fto, Alkbh5, and Ythdc1; main stress effect for Mettl3; each FDR-corrected p < 0.05 and n 2 > 0.01. Asterisk (*) depicts omnibus Tukey post hoc tests to basal p < 0.05. See also Table S2 . Results were replicated in three independent mouse cohorts with only one experiment shown. (E) Global m 6 A/m is decreased in the PFC and increased in the AMY after corticosterone i.p. injection, but not after dexamethasone injection. Corticosterone, 250 mg/ kg; dexamethasone, 10 mg/kg. Global m 6 A/m assay on total RNA, n = 12, mean ± SEM. Two-way ANOVA reported a significant interaction effect (F(4, 96) = 12.887, p < 0.001). Asterisk (*) indicates omnibus Tukey post hoc tests p < 0.05 compared to area basal. See also Figure S3 .
brain's stress response and, given the enrichment of neuronal plasticity and morphogenesis-related terms in the m 6 A/m-seq, synaptic plasticity-related transcripts ( Figures 3D and S4C ). Regulation of m 6 A/m by stress (26/44 transcripts) was observed more often than regulation of RNA (16/44 transcripts, with 12 overlapping) in the transcripts tested. Notably, the majority of chosen candidates were either regulated or expressed in a region-specific manner, emphasizing the importance of assessing Figure S4 . (B) m 6 A/m-RIP-qPCR detects the methylated spike-in oligonucleotide in a linear fashion without impairing precipitation efficiency for endogenous transcripts in the concentration range used for experiments. Methylated spike-in oligo was added to unfragmented total RNA and precipitated with anti-m 6 A/m antibody (m 6 A/m-RIP) or rabbit IgG (IgG NC). n = 3 technical replicates, normalized expression to 1 fmol input control. Mean ± SEM. (C) m 6 A/m-RIP-qPCR accurately quantifies differential methylation of the spike-in oligo. Spike-in oligo (1 fmol) mixed from fully methylated and fully unmethylated spike-in was added to unfragmented total RNA and precipitated with m 6 A/m-RIP-qPCR. n = 3 technical replicates, normalized to input control. Mean ± SEM. (D) Absolute full-length m 6 A/m levels of stress-related and synaptic plasticity-related transcripts are differentially regulated in the PFC and AMY of stress-related candidate transcripts and synaptic-plasticity-related candidate transcripts after stress. See also Figure S4 . n = 8, mean ± SEM. Significant effects observed in FDR-corrected two-way MANOVA (p < 0.05, n 2 > 0.01) are coded in the rows ''m 6 A/m stress effect'' and ''RNA stress effect.'' Orange/blue arrows, PFC-/AMYspecific stress effect (interaction effect two-way ANOVA, one-way follow-up significant in respective tissue); black arrow, stress main effect; equals sign, no interaction or stress main effect in two-way ANOVA. See also Table S2 . (E) The majority of transcripts measured are expressed or regulated in a region-specific manner. Percent of transcripts with significant interaction or main effect in FDR-corrected 232 MANOVA. (F) Stress regulation of m 6 A/m negatively correlates with changes in RNA levels. log2 fold changes of m 6 A/m and RNA after stress to basal time points, n = 44 per group; black line, linear model + 95% CI. For generalized linear models (GLMs), see Table S2 . (G) General patterns of m 6 A/m changes vary in extent and direction depending on brain region and time point. Density plots of data depicted in (D); t test. (H) The m 6 A/m change at the 1 hr time point correlates with the m 6 A/m change at 4 hr in the PFC, but not AMY, indicating that in the PFC, m 6 A/m change 1 hr after stress is a proxy for later change. Orange line, linear model for PFC only + 95% CI. For GLMs, see Table S2 . See also Figure S4 .
RNA methylation in defined brain areas ( Figure 3E ). Interestingly, in contrast to the m 6 A/m-seq, absolute transcript methylation levels m 6 A/m and RNA fold changes negatively correlated, arguing for increased m 6 A/m levels correlating with mRNA decay as previously shown in vitro ( Figure 3F ; Table S2 ; with no influence of region and time point). In detail, both PFC and AMY exhibited differential response at 1 and 4 hr with opposite directions, paralleling the regulation observed in global m 6 A/m in the respective regions above ( Figure 2B ). Overall, 4 hr fold changes had higher effect sizes compared to 1 hr fold changes (Figure 3G) . Fold changes at the 1 hr time point correlated with those at 4 hr for the same gene in the PFC, but not in the AMY, indicating that in the PFC 1 hr m 6 A/m may be an intermediate state of 4 hr regulation with fold changes of regulated m 6 A/m increasing with time. In contrast, in the AMY for the candidate genes investigated, m 6 A/m regulation after 1 and 4 hr was more independent ( Figure 3H ).
Epitranscriptomic Changes in Mice with Conditional
Deletion of Mettl3 or Fto from Adult Neurons Since the expression of the m 6 A methyltransferase Mettl3 and the m 6 A/m demethylase Fto was affected by acute stress, we generated cKO mouse models lacking these genes specifically in adult excitatory neurons employing Mettl3 or Fto flox/flox mice bred to Cre-driver lines. First, to measure the regulation of the epitranscriptome in these mice, we used the Camk2a-Cre driver, which induces gene deletion in excitatory neurons of neocortex and hippocampus (Minichiello et al., 1999) starting 2-3 weeks postnatal , leading to broad reductions of both Mettl3 and Fto mRNA and METTL3 and FTO protein in the adult brain ( Figures 4A, 4B , and S5A). Whereas global m 6 A measured by LC-MS/MS was decreased in cortical mRNA of Mettl3 cKOs (compared to their respective Mettl3 wild-type [WT] littermates), conditional deletion of Fto did not alter m 6 A ( Figures 4C and S5B ). However, using an LC-MS/MS mRNA preparation including a cap-digest similar to previously published protocols , we found that m 6 Am is increased in Fto cKO ( Figure 4D ; significantly increased both relative to Am or A with no change in Am; data not shown). These data confirm FTO primarily targeting m 6 Am in the adult brain in vivo . m 6 Am and Am were below quantification threshold in all of the Mettl3 cKOs, but not Mettl3 WT animals (data not shown), potentially indicating an effect of METTL3 depletion on those nucleosides that should be confirmed with a more sensitive method. Absolute abundancies measured by LC-MS/MS in cortical mRNA were 0.304% for m 6 A/A, 0.022% for m 6 Am/A, and 0.071% for m 6 Am/m 6 A. m 1 A could not be detected in sufficient amounts for quantification in any of the samples (data not shown).
We next profiled m 6 A/m in Mettl3 cKO and Fto cKO mice using m 6 A/m-seq on cortical poly(A)-RNA. Overall, m 6 A/m peaks detected in the single groups were still fairly similar ( Figures  S5C and S5D) , with 80% overlap with the m 6 A/m dataset generated after acute stress ( Figures S5D and S5E ; mainly lacking 5 0 UTR peaks potentially due to use of a different antibody lot). Quantitative analysis of consensus peaks revealed majorly altered epitranscriptomes in both mouse lines (Figures  4E and 4G; Table S3 ), with much higher numbers of consensus m 6 A/m peaks quantitatively altered in Mettl3 cKO compared to WT (1,266) compared to Fto cKO compared to WT (78; both Q < 0.1 and absolute log2 fold change > 0.5), and only a small number shared differentially methylated sites ( Figure S5F ). Although several RNAs are differentially expressed in Metltl3 cKOs or Fto cKOs, they only minorly overlapped with the regulated m 6 A/m peaks in the respective line ( Figure S5F ). Peaks differentially methylated in Mettl3 cKOs and Fto cKOs both showed higher enrichment at the 5 0 UTR compared to all measured peaks ( Figure 4F ). Interestingly, Fto cKO differential peaks do not only localize to the 5 0 UTR, as would be expected from m 6 Am sites only, but also to internal sites, arguing for Fto deletion also affecting internal m 6 A sites. Functionally, while m 6 A/m peaks are enriched in genes related to (mature) synapse and neuronal function, Mettl3 differential m 6 A peaks are more abundant in genes with neuronal and tissue-developmental functions ( Figure S5G ).
Stress-Coping Behavior Is Altered in Mice Deficient in Mettl3 or Fto
To assess behavioral and electrophysiological consequences of Mettl3 and Fto deletion in vivo, we created cKO mice with a more defined gene deletion by breeding Mettl3 or Fto flox/flox mice to Nex-CreERT2 mice in which additionally the gene deletion can be timely controlled by tamoxifen (Agarwal et al., 2012; Mettl3 cKO and Fto cKO) . Upon induction in young adults, Mettl3 and Fto mRNA were depleted from both dorsal and ventral parts of the hippocampus, specifically in CA1 and CA3, but not in the dentate gyrus ( Figure 5A ). METTL3 and FTO proteins were significantly reduced in dCA1/dCA3 in Mettl3 cKO and Fto cKO mice, respectively ( Figures 5B and S6A ). Nex-CreERT2-induced recombination is further known to occur in small populations of principal neurons in the cortex (Agarwal et al., 2012) . Depletion of either gene did not result in compensatory changes of gene expression of other genes involved in m 6 A/m metabolism (Figure S6B ) but altered transcriptome profiles as observed by mRNA-seq of CA1 and CA3 tissue ( Figure 5C ). Interestingly, in non-stressed basal animals, we observed a larger number of differentially expressed genes in Mettl3 cKOs compared to Fto cKOs (Figures 5B and 5C; Mettl3 cKOs, 84 differentially expressed genes; Fto cKOs, 15 differentially expressed genes with Q < 0.1 and an absolute fold change above log2 = 0.5; Table  S4 ), with no apparent preference for up-or downregulation. Although there was only small overlap of differentially expressed genes between the two lines, 104 genes were differentially expressed in a knockout-specific pattern ( Figure 5C ), including genes regulating neuronal activity and synaptic function (examples shown Figure 5D ).
Neither Mettl3 cKO nor Fto cKO mice showed altered anxietylike behavior or locomotion ( Figure S7A ), but we observed significant changes in spontaneous digging behavior ( Figure S7A ). Both knockout mice exhibited increased cued fear memory long-term maintained during memory extinction ( Figure 6A ) as well as contextual fear memory in Fto cKO mice ( Figure 6A ), but no differences in non-fear-related memory or short-term working memory ( Figure 6A ). Next, we investigated the transcriptional response patterns 24 hr after fear conditioning stress; thus, at the time point we observed the altered memory, comparing fear conditioned animals (''FC'') to control animals that experienced the same handling but no foot shock (''Box''). For both Mettl3 cKOs and Fto cKOs, we observed a large number of genes differentially expressed after fear conditioning in a genotype-dependent manner, implying a widely altered transcriptional response pattern after stress in animals with disturbed m 6 A/m system ( Figure 6B ) involving genes crucial for neuronal systems like neurotransmitter receptors and transporters as well as transcription factors ( Figure 6C ). Thereby, significant gene expression regulation was more extended in fear-conditioned animals compared to non-fear-conditioned animals (Figure S7B ; Table S4 ). In contrast to basal animals, Fto cKOs Figure S5 . (E) The m 6 A/m epitranscriptome is widely altered in in Mettl3 cKO and Fto cKO mice. m 6 A/m-seq on mouse cortex poly(A)-RNA of WT and cKO animals reported 1,266 and 78 significantly different methylated m 6 A/m peaks in Mettl3 cKO and in Fto cKO compared to WT, respectively, with 14 shared peaks. n = 3-5, each pooled from 3 mice. WT of both lines were grouped together as we observed no major regulation between them. Shown are log2 fold changes of methylation in cKO relative to WT mice using 10,109 high-confidence consensus m 6 A/m peaks detected across all groups, mapping to 6,056 unique genes. Significantly regulated m 6 A/m peaks are Q < 0.1 and absolute log2 fold change > 0.5. (F) m 6 A/m peaks are enriched at the stop codon with a less prominent enrichment at the 5 0 UTR, as observed in Figure 1 . Differentially methylated peaks in both Mettl3 cKO and Fto cKO mice show an increased preference for 5 0 UTR position with a decreased preference for CDS peaks in Mettl3 cKO differential peaks. Peak distribution mapped along mRNA relative position. Figure S5 and Table S3. showed more genotype-dependent expression changes after the stressful fear conditioning event than Mettl3 cKOs ( Figures  6B and S7B ; Table S4 ), implying that Fto is crucial for the regulation of the fear response despite minor basal changes in gene expression.
Consequently, investigating the effects of Fto and Mettl3 depletion on electrophysiological correlates of network plasticity and brain function, we found that CA1 long-term potentiation was impaired in Fto cKO, but not in Mettl3 cKO, mice ( Figure 6D) , with no effect on paired-pulse facilitation ( Figure 6D ) or basal neurotransmission ( Figure S7C ).
Regulation of m 6 A/m Is Impaired in MDD Patient Blood
To evaluate the potential of blood m 6 A/m as a peripheral proxy of the central m 6 A/m stress response, we measured global m 6 A/m methylation levels in mouse and human blood after an acute stressful challenge and GC stimulation. Global methylation was transiently decreased in whole blood of mice after acute stress ( Figure 7A) , with gene expression of Mettl3 and Alkbh5 altered in accordance with the global m 6 A/m change and Wtap being upregulated ( Figure 7B) . Similarly, global m 6 A/m was decreased in mouse blood 4 hr after i.p. injections of both corticosterone and dexamethasone ( Figure 7C ). Comparably, blood from healthy human volunteers, drawn before and after intake of 1.5 mg dexamethasone, showed both reduced global m 6 A/m levels ( Figure 7D ) and changes in gene expression of the m 6 A/m machinery enzymes 3 hr after dexamethasone intake ( Figure 7E ) (expression data from .
Since dysregulation of the stress response may be an important feature of psychopathologies like major depressive disorder (MDD), we next investigated whether m 6 A/m regulation in response to dexamethasone differs between healthy individuals and MDD patients. In contrast to healthy subjects, downregulation of m 6 A/m in response to dexamethasone was observed in neither male nor female MDD patients ( the transcriptome-wide gene expression values as published in using CellCODE. For the samples used for the m 6 A/m measurements, cell estimates were not found to be significantly different ( Figure S8A ; no significant effects for dexamethasone within any of the cell types or significant effect of the cell types on the dexamethasone 3 diagnosis 3 sex interaction, dexamethasone 3 diagnosis interaction, or dexamethasone main effects was observed). Using the cell estimates for the analysis of global m 6 A/m confirms the earlier observed effect of dexamethasone dependent on subject MDD diagnosis (significant interaction effect of treatment and subject status [F(1, 96) = 10.251, p = 0.002], but no interaction with sex or any significant covariate effect of cell type estimates).
To control for potential contamination of results by antidepressant treatment present in blood of MDD patients, we confirmed the lack of response to GC stimulation using dexamethasone ( Figure S8B ) and cortisol ( Figure 7G , total RNA; Figure 7H , mRNA m 6 A measured specifically by LC/MS-MS) in B lymphocyte cell lines (BLCLs) obtained from six healthy volunteers and six MDD patients propagated in absence of antidepressants. NR3C1 (GC receptor) mRNA and protein expression, as well as transcriptional response to GC stimulation, was unchanged in BLCLs of MDD donors (Figures S8C-S8E) .
To reveal the specific signature of m 6 A/m deregulation in MDD patients, we performed m 6 A/m-seq of BLCLs treated for 1 hr with 100 nM cortisol or mock treatment (n = 3 per genotype and treatment). BLCL m 6 A/m peaks were again found to be very similar across the different groups ( Figures S9A and S9B) , with typical m 6 A/m properties regarding distribution and consensus motif ( Figures S9B and S9C ). m 6 A/m in BLCL are enriched in genes related to stress regulation and metabolic functions ( Figure 8A ). Analyzing the differential response to cortisol of (E) Expression of m 6 A/m regulatory genes in human blood is also affected by dexamethasone. Microarray of human whole blood at baseline and 3 hr after intake of Dex, n = 160 mixed healthy and diseased subjects, mean ± SEM. Asterisks (*) depict Bonferroni-corrected t tests to basal p < 0.05. (F) The dexamethasone-induced m 6 A/m decrease in human blood m 6 A/m is absent in MDD patients. n = 25, male and female, healthy and MDD subjects each, mean ± SEM. Three-way mixed-design ANOVA, significant interaction effect of treatment and subject status (F(1, 96) = 11.184, p = 0.001), but no interaction with sex. Asterisks (*) depict omnibus Tukey post hoc tests to sex basal p < 0.05. (G) Global m 6 A/m is decreased in B lymphocyte cell lines (BLCLs) in a concentration-dependent manner after 1 hr treatment with cortisol. Global m 6 A/m assay on total RNA, n = 5 biological replicates with 3 technical replicates each, mean ± SEM. Two-way ANOVA, significant interaction effect of cortisol and donor status (F(3, 24) = 44.365, p < 0.001). Asterisks (*) depict omnibus Tukey post hoc tests to basal p < 0.05. (H) The same regulation is observed on mRNA m 6 A using LC-MS/MS. n = 5, mean ± SEM. Specific detection of m 6 A. Two-way ANOVA, significant interaction effect of cortisol and donor status (F(1, 20) = 19.196, p < 0.001). Asterisks (*) depict omnibus Tukey post hoc tests to mock treatment p < 0.05. See also Figure S8 . an m 6 A/m consensus peak set (17,665 m 6 A/m peaks), in line with the results of the global m 6 A/m measurements, we observed major changes of m 6 A/m by cortisol in both a donor-dependent fashion (donor 3 treatment interaction effects) and a donor-independent fashion (main cortisol effects), but almost no significant differences by donor status alone, as well as a higher number of The cortisol-responsive m 6 A/m epitranscriptome of healthy and MDD donor BLCLs was analyzed using m 6 A/m-seq comparing 1 hr mock-treated or 100 nM cortisol (Cort) conditions. We found 17,655 consensus high-confidence m 6 A/m peaks across all samples mapping to 8,681 genes. m 6 A/m-seq of each n = 3 BLCLs from healthy and MDD donors, each after 1 hr of mock or cortisol treatment. (A) m 6 A/m peaks in BLCLs are enriched in genes with stress-responsive and metabolic functions. Fifteen highest enriched biological process GO terms with FDRcorrected Q < 0.1. (B) Differential m 6 A/m and gene expression analysis in BLCLs reveals significant regulation of methylation after cortisol treatment with many m 6 A/m peaks regulated by cortisol in a donor-specific fashion and almost absent effects by donor status alone. Gene expression was less regulated than m 6 A/m regulation, lacking any donor-specific effects by cortisol. Number of significantly regulated peaks/genes with Q < 0.1 and absolute log2 fold change > 0.5, reporting 2 3 2 and post hoc effects within the single donor groups. Peaks and genes with significant interaction effects are removed from main treatment and main donor effect. (C) Many peaks are regulated by cortisol in a donor-specific fashion. log2 fold changes of m 6 A/m peaks by cortisol within each donor group; significant peaks defined as above. (D) m 6 A/m peaks in BLCLs show similar peak position enrichments as m 6 A/m peaks in mouse brain with preference for cortisol-regulated peaks at 5 0 UTR and CDS. Peak distribution mapped along mRNA relative position. (E) m 6 A/m peaks regulated by cortisol alone (main effect) have higher fold changes in healthy donors compared to BLCLs from MDD donors. (F) Assessing absolute transcript methylation using m 6 A/m-RIP-qPCR, the cortisol-responsive genes FKBP5, IRS2, and TSC22D3 m 6 A/m were found specifically downregulated in cell lines of healthy, but not MDD, donors after stimulation with cortisol (cort). m 6 A/m-RIP-qPCR. n = 5, mean ± SEM. Significant effects observed in FDR-corrected two-way MANOVA (p < 0.05) are coded in the rows ''m 6 A/m Cort effect'' and ''RNA Cort effect.'' Orange arrows, healthy donorspecific Cort effect (interaction effect two-way ANOVA, one-way follow-up significant in healthy donors only); black arrow, Cort main stress effect; equals sign, no interaction or stress main effect in two-way ANOVA. For full statistics, see Table S2 . (G) Density plots of m 6 A/m change upon cortisol treatment. Density plots of log2 fold change data as m 6 A/m-RIP-qPCR data depicted in (F); donor-dependent distributions of fold changes were compared using a t test. See also Figure S9 and Table S5. cortisol-regulated m 6 A/m peaks in healthy compared to MDD donor cell lines (Figures 8B and 8C; Table S5 ; example peaks in Figure S9D ; top 25 regulated m 6 A/m peaks and RNAs in Figures S9F and S9G; all Q < 0.1, absolute log2 fold change > 0.5). Cortisol main and donor-interaction-regulated m 6 A/m peaks both showed a preference for location in the CDS and 5 0 UTR ( Figure 8D) with the donor-dependent cortisol-regulated peaks enriched in catabolic genes ( Figure S9E) , i.e., genes involved in energy-providing metabolic processes. Similar to the regulation of global m 6 A/m being more prominent in healthy donor BLCLs, m 6 A/m peaks regulated by cortisol were most often regulated in cells from healthy rather than MDD donor cells ( Figures 8C and 8E) .
Finally, to confirm the differential regulation of m 6 A/m levels in BLCLs from healthy and MDD donors, we performed m 6 A/m-RIP-qPCR testing for GC-responsive genes in BLCLs after stimulation with cortisol. We observed specific downregulation of m 6 A/m in FKBP5, IRS2, and TSC22D3 in cells from healthy, but not from MDD, individuals ( Figure 8F ). In line with the general trends observed before, methylation of tested candidates in cells derived from healthy, but not MDD, donors was significantly decreased ( Figure 8G ).
DISCUSSION
Here, we have identified m 6 A and m 6 Am as epitranscriptomic marks responsive to acute stress. Using m 6 A/m-seq in mouse cortex and m 6 A/m profiling in smaller areas by m 6 A/m-RIP-qPCR, we provide a map of brain m 6 A/m and evidence for regulation of m 6 A/m by acute stress. Consequently, in mice with METTL3 and FTO depleted in adult excitatory neurons and consequently altered m 6 A and m 6 Am profiles, we observed changes in transcriptome regulation, behavior, and electrophysiological properties. Finally, we observed that regulation of m 6 A/m and its cellular machinery in blood may represent a peripheral proxy for part of the brain's m 6 A/m responses that seems impaired in patients with a stress-related disorder, MDD.
In the m 6 A/m-seq of mouse cortex, we remapped mouse cortical m 6 A/m, describing a higher amount of 5 0 UTR peaks than previously reported . A part of these 5 0 UTR peaks may represent m 6 Am sites, although we did not observe any different properties of these putative m 6 Am peaks compared to general m 6 A/m peaks. We further add the observation that m 6 A sites in vivo overlap with the neuronal RNA-binding and cell-transport-regulating protein FMRP/FMR1-binding sites. FMR1 has recently been shown to bind m 6 A/m (Edupuganti et al., 2017) , suggesting that it may be an important m 6 A reader in the brain. Future work is needed to investigate the nature of FMR1 binding to m 6 A/m and the effects of this binding in neurons, including potential roles in transcript localization to specialized neuronal compartments as axons and dendrites and potential regulation of local synaptic translation. Investigating a potential general relation of stress-regulated m 6 A/m regulating transcript translation, we could not find evidence for this.
Overall, only a very small number of m 6 A/m peaks in m 6 A/mseq was found to be stress regulated. This is likely due to the large cellular heterogeneity of the material used; thus, only a small fraction of cells would have been responsive to the treatment and thus there was limited sensitivity of the assay to detect changes. Indeed, we find that m 6 A/m regulation is highly specific to smaller brain areas with even often opposite regulation in different areas as shown in the example of PFC being globally hypomethylated after stress and the AMY globally hypermethylated; this effect was confirmed by specific m 6 A detection being majorly driven by m 6 A. These two areas regulate behavioral and hormonal stress responses, fear, and anxiety (McEwen et al., 2015) , with the PFC exhibiting top-down control of the AMY in anxiety and fear in mice (Adhikari et al., 2015) . These changes were accompanied by matching regulation in the demethylase Fto and Alkbh5 expression, as well as regulation of the methyltransferase Mettl3. Interestingly, previous reports also showed transcriptional regulation of Fto after acute stress by fear conditioning (Walters et al., 2017; Widagdo et al., 2016) .
Although we observed a general negative correlation between absolute m 6 A/m change and RNA abundance in m 6 A/m-RIP-qPCR, most m 6 A/m changes were not accompanied by significant transcript changes in m 6 A/m-RIP-qPCR or m 6 A/m-seq, implying that differential m 6 A/m acts by regulating both RNA decay and location and translation control.
Notably, we observe that corticosterone i.p. injection in mice causes similar effects on m 6 A/m and enzyme expression as acute stress, pointing toward a potential signaling mechanism via centrally acting GCs. Additional work is needed to unravel the pertinent signaling cascades involved. It is currently unclear which of the cell types drive the observed effects on m 6 A/m, with likely all major brain cell types having m 6 A/m and expression of the respective machinery genes (as observed by single-cell RNA-seq; data not shown).
To more specifically investigate the mechanisms of m 6 A/m methylation in adult excitatory neurons only, we employed cKO mice using Camk2a-Cre and Nex-CreERT2 drivers. Interestingly, while METTL3 deletion reduced m 6 A as expected, FTO deletion did not alter m 6 A levels but increased m 6 Am levels. However, m 6 A/m peaks differentially methylated in Fto cKO mice were not only positioned at the 5 0 UTR, but also in CDS and 3 0 UTR, pointing at FTO not only affecting m 6 Am, but a large part . In general, epitranscriptomic and transcriptomic signatures of Mettl3 cKO and Fto cKO brain tissue were substantially different, indicating that both enzymes in neurons of the adult brain have different targets and likely very different functions. Interestingly, both Nex-CreERT2 knockout mice had very similar behavioral profiles, including lack of effects on anxiety and general cognition but increased fear memory for cued fear (with Fto cKO mice additionally having increased contextual fear) with stable differences of memory across time and fear extinction training, extending the previously reported fear expression upon knockdown of Fto in the dorsal hippocampus (Walters et al., 2017) and in the PFC (Widagdo et al., 2016) . This indicates that fear-memory acquisition as well as its stability to extinction may require fine-tuned regulation of m 6 A/m levels rather than being directly regulated by specific m 6 A/m levels at specific genes. Mechanistically, we found that Mettl3 and Fto depletion alters not only the steady-state transcriptome in adult hippocampal neurons, but also the transcriptomic response to the fear conditioning stress, including regulation of several genes involved in neuronal circuit function and pointing out a function of m 6 A/m in regulating neuronal circuits. Consequently, we describe that network plasticity is specifically altered in the CA1, a brain region crucial for contextual fear, in Fto cKO, but not Mettl3 cKO, mice. This may reflect a neuronal correlate of altered m 6 A/m underlying the altered contextual fear memory observed in Fto cKO mice.
Finally, we propose that regulation of m 6 A/m and its cellular machinery in blood may represent a peripheral proxy for part of the brain's m 6 A/m response, similar to DNA methylation changes (Ewald et al., 2014; Provenç al et al., 2012) . Both mice and humans showed global blood demethylation after stress or GC intake, respectively. The m 6 A/m response to GCs is impaired in blood and blood cells obtained from MDD patients, which may be a consequence of the altered GC receptor downstream signaling reported in MDD (de Kloet et al., 2005) . While limited in sample size, these data represent a first step for future studies aiming to assess m 6 A/m in human samples as potential biomarkers or for mechanistic investigations and show the feasibility of such studies. Interestingly, genetic variants in FTO (Milaneschi et al., 2014; Samaan et al., 2013) and ALKBH5 (Du et al., 2015) have been reported to associate with risk for MDD before but are yet to be replicated in larger cohorts. Growing evidence supports fine-tuning of transcriptional regulation is critical for psychiatric disorders including various epigenetic mechanisms (Klengel and Binder, 2015) . Here, we reveal RNA modifications as a novel mechanism relevant for understanding psychiatric disorders.
In summary, m 6 A and m 6 Am methylation constitute a novel layer of complexity in gene expression regulation following stress exposure, which is pivotal for the adaptation of stressresponsive circuits to acute challenges. The exciting finding of m 6 A/m dysregulation in MDD opens the possibility for the development of novel diagnostic biomarkers and eventually to better treatments for anxiety disorders, depression, and other stressrelated diseases.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Alon Chen (alon_chen@psych.mpg.de).
EXPERIMENTAL MODEL AND SUBJECT DETAILS Animals
All experiments were approved by and conducted in accordance with the regulations of the local Animal Care and Use Committee (Government of Upper Bavaria, Munich, Germany and Weizmann Institute of Science, Rehovot, Israel).
For all experiments characterizing m 6 A/m changes after stress, 10-12 w old adult C57 BL/6 male mice were used (Charles River, Sulzfeld, Germany). Mettl3 cKO and Fto cKO mice were generated by breeding Mettl3 tm1c(KOMP)Wtsi lox/lox mice (derived from Mettl3 tm1a(KOMP)Wtsi V6.5 mouse ESCs targeted as described in mice generated by Geula et al., 2015) or Fto tm1c(EUCOMM)Wtsi lox/lox mice derived from Fto tm1a(EUCOMM)Wtsi obtained from EMMA (EM: 05094) to Camk2a-Cre mice (Minichiello et al., 1999) or Nex-CreERT2 mice (Agarwal et al., 2012) , respectively. Camk2a-Cre mice crossed mice were used for LC-MS/MS and m 6 A/m Seq (Figure 4) , Nex-CreERT2 crossed mice were used for mRNA-Seq, behavioral characterization and electrophysiological characterization ( Figures 5 and 6) . Experimental mice were homozygous floxed Cre-positive (Cre/+, ''cKO'') and Cre-negative (+/+, ''WT'') littermates generated by breeding of homozygous floxed mice negative and hemizygous for the CreERT2-allele. All Nex-CreERT2 crossed mice were fed with tamoxifen-containing chow (Genobios LASCR diet Cre Active TAM 400) starting at the age of 4-6 w. 
Gene expression analysis
Statistics were performed on log2 normalized data using a 2x2 MANOVA in SPSS and were multiple testing-corrected by the Benjamini-Hochberg test (cut-off Q < 0.05) in R and a cut-off by effect size (h 2 > 0.01) and post hoc testing (Tukey HSD).
Candidate m 6 A/m-RIP-qPCR analysis RNA abundance levels were quantified from the input samples using the ddCT method normalizing to the average of all housekeeping genes. Immunoprecipitation efficiency for each biological sample was assessed using the measured abundance of spike-in per m 6 A/m-RIP/IgG control sample. Because all conditions per sample were equally split at the beginning, % methylation or IgG signal was calculated as follows: Ã 1000
Statistics were performed on log2 normalized data (RNA) or absolute values (m 6 A/m) using a 2x2 MANOVA in SPSS with multiple testing performed using the Benjamini-Hochberg method (cut-off Q < 0.05) in R and a cut-off by effect size (h 2 > 0.01) and post hoc testing (Tukey HSD). (Faul et al., 2007) using a = 0.05 and an experience-based b. Animals and samples within experiments were randomized using stratified randomization assisted by random number generation.
Statistical analysis

DATA AND SOFTWARE AVAILABILITY
All supporting data and code for this study are available from the corresponding author upon request. Sequencing data are deposited at GEO: GSE113801 with subseries GSE113781 (m 6 A/m-Seq mouse cortex after acute stress), GSE113789 (Ribosome profiling Seq mouse cortex after acute stress), GSE113793 (m 6 A/m-Seq of mouse adult cortex of Mettl3 cKO or Fto cKO mice), GSE113796 (mRNA-Seq of mouse Mettl3 cKO or Fto cKO mouse hippocampus after fear conditioning), GSE113798 (m 6 A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients).
